Literature DB >> 25440907

Activation of Toll-like receptors by intestinal microflora reduces radiation-induced DNA damage in mice.

Hong Chen1, Zhi-Dong Wang2, Mao-Sheng Chen3, Xue-Qing Zhang3, Li-Ping Shen3, Jian-Xiang Zhang4, Ying Chen5.   

Abstract

Activation of Toll-like receptors (TLRs) signaling by intestinal microflora-derived bacterial products plays a key role in injury defence for the host. We investigated the role of TLRs activated by intestinal microflora in radiation-induced DNA damage in mice. We analyzed DNA damage induced by 2Gy γ-ray radiation in an intestinal commensal bacteria-depleted mouse model (CD group), in which TLRs (TLR2/6, TLR4 and TLR5) ligand levels in serum were reduced. Chromosomal aberrations were measured in bone marrow cells and peripheral blood leukocyte comet assays were performed. DNA damage was increased in the CD group compared with the control group. Treatment of mice with TLR agonists (CBLB502, LPS and lipopeptide) 1h before radiation resulted in a significant decrease in DNA damage. Genes induced by TLR5 activation were analyzed; activation of TLRs regulated the expression of Gadd45b, Sod2, and Rad21, which are involved in DNA damage repair. In summary, our data indicate that TLRs activation by intestinal microflora reduces DNA damage induced by radiation and regulates expression of several DNA repair genes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chromosome aberration; DNA damage; Intestinal microflora; Irradiation; TLRs

Mesh:

Substances:

Year:  2014        PMID: 25440907     DOI: 10.1016/j.mrgentox.2014.09.001

Source DB:  PubMed          Journal:  Mutat Res Genet Toxicol Environ Mutagen        ISSN: 1383-5718            Impact factor:   2.873


  6 in total

1.  Genetic analysis of radiation-specific biomarkers in sinonasal squamous cell carcinomas.

Authors:  Li Yan; Cheng Zhan; Shengzi Wang; Shuyi Wang; Luo Guo
Journal:  Tumour Biol       Date:  2016-05-10

Review 2.  Radiation takes its Toll.

Authors:  Josephine A Ratikan; Ewa D Micewicz; Michael W Xie; Dörthe Schaue
Journal:  Cancer Lett       Date:  2015-03-25       Impact factor: 8.679

3.  Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Authors:  Pataje G S Prasanna; Deepa Narayanan; Kory Hallett; Eric J Bernhard; Mansoor M Ahmed; Gregory Evans; Bhadrasain Vikram; Michael Weingarten; C Norman Coleman
Journal:  Radiat Res       Date:  2015-08-18       Impact factor: 2.841

4.  The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome.

Authors:  Cathryn J Kurkjian; Hao Guo; Nathan D Montgomery; Ning Cheng; Hong Yuan; Joseph R Merrill; Gregory D Sempowski; W June Brickey; Jenny P-Y Ting
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

Review 5.  A Potential Role of Salmonella Infection in the Onset of Inflammatory Bowel Diseases.

Authors:  Bárbara M Schultz; Carolina A Paduro; Geraldyne A Salazar; Francisco J Salazar-Echegarai; Valentina P Sebastián; Claudia A Riedel; Alexis M Kalergis; Manuel Alvarez-Lobos; Susan M Bueno
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

6.  Radioprotective effect of newly synthesized toll-like receptor 5 agonist, KMRC011, in mice exposed to total-body irradiation.

Authors:  Jun-Young Kim; Jong-Hyung Park; Sun-Min Seo; Jin-Il Park; Hee-Yeon Jeon; Han-Kyul Lee; Ran-Ji Yoo; Yong-Jin Lee; Sang-Keun Woo; Woo-Jong Lee; Chi-Min Choi; Yang-Kyu Choi
Journal:  J Radiat Res       Date:  2019-07-01       Impact factor: 2.724

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.